NCT03479073View on ClinicalTrials.gov

Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation

CompletedOBSERVATIONAL
Enrollment

3,198

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

June 14, 2018

Study Completion Date

June 14, 2018

Conditions
Atrial Fibrillation
Trial Locations (3)

Unknown

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanmi Pharmaceutical Company Limited

INDUSTRY

lead

Korea University Guro Hospital

OTHER

NCT03479073 - Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter